Advanced in Premature Infant

Dr. Joseph B. Domachowske

Pediatric Infectious Disease | Infectious Disease | Pediatrics
Pediatric Service Group
750 E Adams St, Fl 3, 
Syracuse, NY 
Advanced in Premature Infant
Pediatric Service Group
750 E Adams St, Fl 3, 
Syracuse, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joseph Domachowske is a Pediatric Infectious Disease specialist and an Infectious Disease provider in Syracuse, New York. Dr. Domachowske is rated as an Advanced provider by MediFind in the treatment of Premature Infant. His top areas of expertise are Parainfluenza, Premature Infant, Flu, and H1N1 Influenza.

His clinical research consists of co-authoring 96 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Premature Infant.

Specialties
Pediatric Infectious Disease
Infectious Disease
Pediatrics
Licenses
Pediatric Infectious Diseases in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

PEDIATRIC SERVICE GROUP
750 E Adams St, Fl 3, Syracuse, NY 13210

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II, Observer-blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of a Varicella Vaccine at Various Potencies Compared With Varivax, as a First Dose, Administered in Healthy Children in Their Second Year of Life
A Phase II, Observer-blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of a Varicella Vaccine at Various Potencies Compared With Varivax, as a First Dose, Administered in Healthy Children in Their Second Year of Life
Enrollment Status: Completed
Publish Date: February 28, 2025
Intervention Type: Biological
Study Phase: Phase 2
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
A Phase III, Observer-blind, Randomized, Multi-country Study to Assess the Reactogenicity and Safety of the Porcine Circovirus (PCV) Free Liquid Formulation of GSK's Oral Live Attenuated Human Rotavirus (HRV) Vaccine as Compared to the Lyophilized Formulation of the GSK's HRV Vaccine, When Administered as a 2-dose Vaccination in Infants Starting at Age 6-12 Weeks
A Phase III, Observer-blind, Randomized, Multi-country Study to Assess the Reactogenicity and Safety of the Porcine Circovirus (PCV) Free Liquid Formulation of GSK's Oral Live Attenuated Human Rotavirus (HRV) Vaccine as Compared to the Lyophilized Formulation of the GSK's HRV Vaccine, When Administered as a 2-dose Vaccination in Infants Starting at Age 6-12 Weeks
Enrollment Status: Completed
Publish Date: March 10, 2022
Intervention Type: Biological
Study Phase: Phase 3
View 2 Less Clinical Trials

96 Total Publications

Vaccine attitudes, practices, and literacy among New York State primary care providers and their office personnel.
Vaccine attitudes, practices, and literacy among New York State primary care providers and their office personnel.
Journal: Human vaccines & immunotherapeutics
Published: July 16, 2025
Similar Doctors
Experienced in Premature Infant
Dr. Michelle M. Bode
Neonatology | Pediatrics
Experienced in Premature Infant
Dr. Michelle M. Bode
Neonatology | Pediatrics
725 Irving Ave Rm 107, 
Syracuse, NY 
 (1.0 miles away)
315-470-7735
Languages Spoken:
English
See accepted insurances

Michelle Bode is a Neonatologist and a Pediatrics provider in Syracuse, New York. Dr. Bode is rated as an Experienced provider by MediFind in the treatment of Premature Infant. Her top areas of expertise are Premature Infant, Bronchopulmonary Dysplasia, and Infant Respiratory Distress Syndrome.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Domachowske's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile